{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T12:38:01Z","timestamp":1778848681029,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":646,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1093\/annonc\/mdy021","type":"journal-article","created":{"date-parts":[[2018,1,18]],"date-time":"2018-01-18T18:13:32Z","timestamp":1516299212000},"page":"966-972","source":"Crossref","is-referenced-by-count":19,"title":["Genetic landscape of ultra-stable chronic lymphocytic leukemia patients"],"prefix":"10.1016","volume":"29","author":[{"given":"S.","family":"Raponi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Del Giudice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Marinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Cafforio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Ilari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Piciocchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Messina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Bonina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Tavolaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bordyuh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Mariglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Peragine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.R.","family":"Mauro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Chiaretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Molica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Visentin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Trentin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.M.","family":"Rigolin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Cuneo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Diop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Gaidano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Guarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Rabadan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Fo\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1093\/annonc\/mdy021_bb0010","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nrc.2016.8","article-title":"The molecular pathogenesis of chronic lymphocytic leukaemia","volume":"16","author":"Fabbri","year":"2016","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"10.1093\/annonc\/mdy021_bb0015","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/leu.2012.25","article-title":"ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia","volume":"26","author":"Pospisilova","year":"2012","journal-title":"Leukemia"},{"issue":"1","key":"10.1093\/annonc\/mdy021_bb0020","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3324\/haematol.2011.049270","article-title":"ATM gene alterations in chronic lymphocytic leukemia patients induce a distinct gene expression profile and predict disease progression","volume":"97","author":"Guarini","year":"2012","journal-title":"Haematologica"},{"issue":"5","key":"10.1093\/annonc\/mdy021_bb0025","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3324\/haematol.2012.069369","article-title":"Clinical implications of the molecular genetics of chronic lymphocytic leukemia","volume":"98","author":"Fo\u00e0","year":"2013","journal-title":"Haematologica"},{"issue":"8","key":"10.1093\/annonc\/mdy021_bb0030","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1182\/blood-2012-09-458265","article-title":"Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia","volume":"121","author":"Rossi","year":"2013","journal-title":"Blood"},{"issue":"14","key":"10.1093\/annonc\/mdy021_bb0035","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1182\/blood-2013-11-539726","article-title":"Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia","volume":"123","author":"Rossi","year":"2014","journal-title":"Blood"},{"issue":"11","key":"10.1093\/annonc\/mdy021_bb0040","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1182\/blood-2010-12-327858","article-title":"Acquired genomic copy number aberrations and survival in chronic lymphocytic leukemia","volume":"118","author":"Ouillette","year":"2011","journal-title":"Blood"},{"issue":"24","key":"10.1093\/annonc\/mdy021_bb0045","doi-asserted-by":"crossref","first-page":"4783","DOI":"10.1182\/blood-2012-04-423517","article-title":"High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations","volume":"120","author":"Edelmann","year":"2012","journal-title":"Blood"},{"issue":"3","key":"10.1093\/annonc\/mdy021_bb0050","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1182\/blood-2002-12-3639","article-title":"Chronic lymphocytic leukemia patients with highly stable and indolent disease show distinctive phenotypic and genotypic features","volume":"102","author":"Guarini","year":"2003","journal-title":"Blood"},{"issue":"12","key":"10.1093\/annonc\/mdy021_bb0055","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1038\/sj.leu.2403537","article-title":"Evidence of biased immunoglobulin variable gene usage in highly stable B-cell chronic lymphocytic leukemia","volume":"18","author":"Capello","year":"2004","journal-title":"Leukemia"},{"issue":"4","key":"10.1093\/annonc\/mdy021_bb0060","doi-asserted-by":"crossref","first-page":"626","DOI":"10.3324\/haematol.2010.028779","article-title":"White blood cell count at diagnosis and immunoglobulin variable region gene mutations are independent predictors of treatment-free survival in young patients with stage A chronic lymphocytic leukemia","volume":"96","author":"Del Giudice","year":"2011","journal-title":"Haematologica"},{"issue":"19","key":"10.1093\/annonc\/mdy021_bb0065","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.1182\/blood-2011-11-393694","article-title":"Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies","volume":"119","author":"Agathangelidis","year":"2012","journal-title":"Blood"},{"issue":"Suppl 5","key":"10.1093\/annonc\/mdy021_bb0070","doi-asserted-by":"crossref","first-page":"v78","DOI":"10.1093\/annonc\/mdv303","article-title":"Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"26","author":"Eichhorst","year":"2015","journal-title":"Ann Oncol"},{"issue":"26","key":"10.1093\/annonc\/mdy021_bb0075","doi-asserted-by":"crossref","first-page":"6904","DOI":"10.1182\/blood-2011-08-373159","article-title":"Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness","volume":"118","author":"Rossi","year":"2011","journal-title":"Blood"},{"issue":"2","key":"10.1093\/annonc\/mdy021_bb0080","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1182\/blood-2011-09-379966","article-title":"Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia","volume":"119","author":"Rossi","year":"2012","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdy021_bb0085","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1182\/blood-2011-12-395673","article-title":"Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia","volume":"1","author":"Rossi","year":"2012","journal-title":"Blood"},{"issue":"14","key":"10.1093\/annonc\/mdy021_bb0090","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1002\/cncr.25113","article-title":"Protein kinase gene expression profiling and in vitro functional experiments identify novel potential therapeutic targets in adult acute lymphoblastic leukemia","volume":"116","author":"Messina","year":"2010","journal-title":"Cancer"},{"issue":"3","key":"10.1093\/annonc\/mdy021_bb0095","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1182\/blood-2008-12-196568","article-title":"Spontaneous regression of chronic lymphocytic leukemia: clinical and biologic features of 9 cases","volume":"114","author":"Del Giudice","year":"2009","journal-title":"Blood"},{"issue":"7354","key":"10.1093\/annonc\/mdy021_bb0100","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature10113","article-title":"Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia","volume":"475","author":"Puente","year":"2011","journal-title":"Nature"},{"issue":"26","key":"10.1093\/annonc\/mdy021_bb0105","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1109016","article-title":"SF3B1 and other novel cancer genes in chronic lymphocytic leukemia","volume":"365","author":"Wang","year":"2011","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1093\/annonc\/mdy021_bb0110","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/ng.1032","article-title":"Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia","volume":"44","author":"Quesada","year":"2012","journal-title":"Nat Genet"},{"issue":"7574","key":"10.1093\/annonc\/mdy021_bb0115","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nature15395","article-title":"Mutations driving CLL and their evolution in progression and relapse","volume":"526","author":"Landau","year":"2015","journal-title":"Nature"},{"issue":"15","key":"10.1093\/annonc\/mdy021_bb0120","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1182\/blood-2013-10-534271","article-title":"Genetic lesions associated with chronic lymphocytic leukemia chemo-refractoriness","volume":"123","author":"Messina","year":"2014","journal-title":"Blood"},{"issue":"9","key":"10.1093\/annonc\/mdy021_bb0125","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1158\/1078-0432.CCR-15-2123","article-title":"Genetic landscapes of relapsed and refractory diffuse large B-cell lymphomas","volume":"22","author":"Morin","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"11","key":"10.1093\/annonc\/mdy021_bb0130","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ng.3415","article-title":"Integrated molecular analysis of adult T cell leukemia\/lymphoma","volume":"47","author":"Kataoka","year":"2015","journal-title":"Nat Genet"},{"issue":"4","key":"10.1093\/annonc\/mdy021_bb0135","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.cell.2013.01.019","article-title":"Evolution and impact of subclonal mutations in chronic lymphocytic leukemia","volume":"152","author":"Landau","year":"2013","journal-title":"Cell"},{"issue":"6","key":"10.1093\/annonc\/mdy021_bb0140","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/leu.2016.10","article-title":"Longitudinal copy number, whole exome and targeted deep sequencing of \u2018good risk\u2019 IGHV-mutated CLL patients with progressive disease","volume":"30","author":"Rose-Zerilli","year":"2016","journal-title":"Leukemia"},{"issue":"7574","key":"10.1093\/annonc\/mdy021_bb0145","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature14666","article-title":"Non-coding recurrent mutations in chronic lymphocytic leukaemia","volume":"526","author":"Puente","year":"2015","journal-title":"Nature"},{"issue":"2","key":"10.1093\/annonc\/mdy021_bb0150","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/leu.2014.196","article-title":"Recurrent mutations refine prognosis in chronic lymphocytic leukemia","volume":"29","author":"Baliakas","year":"2015","journal-title":"Leukemia"},{"issue":"4","key":"10.1093\/annonc\/mdy021_bb0155","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/leu.2014.297","article-title":"Detailed analysis of therapy-driven clonal evolution of TP53 mutations in chronic lymphocytic leukemia","volume":"29","author":"Malcikova","year":"2015","journal-title":"Leukemia"},{"issue":"1","key":"10.1093\/annonc\/mdy021_bb0160","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/leu.2008.260","article-title":"A subset of Binet stage A CLL patients with TP53 abnormalities and mutated IGHV genes have stable disease","volume":"23","author":"Best","year":"2009","journal-title":"Leukemia"},{"issue":"11","key":"10.1093\/annonc\/mdy021_bb0165","doi-asserted-by":"crossref","first-page":"e231","DOI":"10.3324\/haematol.2014.108365","article-title":"Genomic complexity and IGHV mutational status are key predictors of outcome of chronic lymphocytic leukemia patients with TP53 disruption","volume":"99","author":"Delgado","year":"2014","journal-title":"Haematologica"},{"issue":"3","key":"10.1093\/annonc\/mdy021_bb0170","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1158\/1078-0432.CCR-16-0594","article-title":"Survival of Del17p CLL depends on genomic complexity and somatic mutation","volume":"23","author":"Yu","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1093\/annonc\/mdy021_bb0175","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1470-2045(16)30029-8","article-title":"An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data","volume":"17","author":"International CLL-IPI working group","year":"2016","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1093\/annonc\/mdy021_bb0180","doi-asserted-by":"crossref","first-page":"E91","DOI":"10.1002\/ajh.24707","article-title":"Reliability of six prognostic models to predict time-to-first-treatment in patients with chronic lymphocytic leukaemia in early phase","volume":"92","author":"Molica","year":"2017","journal-title":"Am J Hematol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419454677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419454677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/29\/4\/966\/24702599\/mdy021.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T09:41:00Z","timestamp":1624700460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419454677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0923753419454677"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdy021","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]}}}